Transcription of AUGMENTING GROWTH ENGINES - SUN Pharma
{{id}} {{{paragraph}}}
Example: air traffic controller
AUGMENTING GROWTH ENGINES - SUN Pharma
2016-2017 AUGMENTINGGROWTHENGINESR eaching People. Touching PHARMACEUTICAL INDUSTRIES Performance Indicators08 Management Discussion and Analysis80 Standalone Financial Statements03 Ten Year Financial Highlights32 Board s Report170 Consolidated Financial Statements04 Managing Director s Letter62 Corporate GovernanceThe cover design of this year s annual report focuses on the theme of AUGMENTING GROWTH ENGINES . It takes an abstract approach to illustrating multifaceted connections that come together to drive GROWTH , which is representative of multiple GROWTH People. Touching PHARMACEUTICAL INDUSTRIES STATEMENTSCORPORATE OVERVIEW80-27800-001 ANNUAL REPORT 2016-1701-07 STATUTORY REPORTS 08-79At Sun Pharma , we have consistently focused on AUGMENTING the long-term GROWTH drivers for the Company. As a part of this approach, we have added another GROWTH engine to our business - the specialty business which is gradually evolving for us.
2 sun pharmaceutical industries limited key performance indicators (consolidated) total income (` in million) 35,017 44,808 42,123 60,827 84,910 116,880
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Product, Practices for Extractable and, Practices for Extractable and Leachables, English ALL PUPIL II, Development, INJECTABLE DRUG DELIVERY 2013:, INJECTABLE DRUG DELIVERY 2013: FORMULATIONS FOCUS, AnnualReport 2016 – 2017, Extractables, Leachables & Elemental Impurities, 2016 Top Markets Report Medical Devices